CD44
isoforms, such as CD44s (the standard form), contain at least one
ankyrin-binding site within the 70-amino
acid (aa) cytoplasmic domain and several
hyaluronic acid (HA)-binding sites within the extracellular domain. To study the role of CD44s-ankyrin interaction in regulating human prostate
tumor cells, we have constructed several CD44s cytoplasmic deletion mutants that lack the
ankyrin-binding site(s). These truncated cDNAs were stably transfected into CD44-negative human prostate
tumor cells (LNCaP). Our results indicate that a critical region of 15-amino
acids (aa) between aa 304 and aa 318 of CD44s is required for
ankyrin binding. Biochemical analyses, using competition binding assays with a synthetic
peptide containing the 15 aa between aa 304 and aa 318 (NSGNGAVEDRKPSGL), further support the conclusion that this region contains the
ankyrin-binding domain of CD44s. Deletion of this 15-aa
ankyrin-binding sequence from CD44s results in a drastic reduction of HA-mediated binding/cell adhesion, Src p60
kinase(s) interaction and anchorage-independent growth in soft
agar. These findings suggest that the binding of
cytoskeletal proteins, such as
ankyrin, to the cytoplasmic domain of CD44s plays a pivotal role in regulating HA-mediated functions as well as
Src kinase activity and prostate
tumor cell transformation.